Targeted radiotherapy using Auger electron emitters

Physics in Medicine and Biology

Volumn 41, Issue 10, 1996, Pages 1973-1992

  O'Donoghue, J A ^a   Wheldon, T E ^b,c  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

^c BEATSON WEST OF SCOTLAND CANCER CENTRE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

OLIGONUCLEOTIDE; RADIOISOTOPE;

ARTICLE; CANCER RADIOTHERAPY; CELLULAR DISTRIBUTION; CYTOTOXICITY; DNA SEQUENCE; HALF LIFE TIME; MATHEMATICAL MODEL; MULTIMODALITY CANCER THERAPY; PRIORITY JOURNAL;

ESTROGENS; GROWTH SUBSTANCES; HALF-LIFE; HUMANS; IODINE RADIOISOTOPES; MODELS, THEORETICAL; NEOPLASMS; OLIGONUCLEOTIDES; RADIOISOTOPES; RADIOTHERAPY; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0029743456     PISSN: 00319155     EISSN: None     Source Type: Journal    
DOI: 10.1088/0031-9155/41/10/009     Document Type: Article

References (81)

1. Adelstein S J 1993 The Auger process: a therapeutic promise? Am. J. Roentgen. 160 707-13
2. 125I-labelled internalized and non-internalized monoclonal antibodies in nude mice with human colon carcinoma xenografts Nucl. Med. Biol. 20 133-44
3. 125I] iodo-17-beta-estradiol J. Cancer Res. Clin. Oncol. 119 207-14
4. Bigner S H, Burger P C, Wong A J, Werner M H, Hamilton S R, Muhlbaier L H, Vogelstein B and Bigner D D 1988 Gene amplification in malignant human gliomas: clinical and histopathological aspects J. Neuropathol. Exp. Neurol. 47 191-205
5. Bloomer W D, McLaughlin W H, Weichselbaum R R, Hanson R N, Adelstein S J and Seitz D E 1981 The role of subcellular localization in assessing the cytotoxicity of iodine-125 labelled iododeoxyuridine, iodotamoxifen and iodoantipyrine J. Radioannal. Chem. 65 209-21
6. Boado R J 1995 Antisense drug delivery through the blood-brain barrier Adv. Drug Delivery Rev. 15 73-107
7. Brodeur G M and Fong C T 1989 Molecular biology and genetics of human neuroblastoma Cancer Genet. Cytogenet. 41 153-74
8. 125I in cell DNA at -196°C Int. J. Radiat. Biol. 24 363-75
9. Carlsson J et al 1994 Strategy for boron neutron capture therapy against tumor cells with over-expression of the epidermal growth factor-receptor Int. J. Radiat. Oncol. Biol. Phys. 30 105-15
10. Carroll R S, Zhang J P, Dashner K, Sar M and Black P M 1995 Steroid hormone receptors in astrocytic neoplasms Neurosurgery 37 496-503
11. Carson-Jurica M A, Schrader W T and O'Malley B W 1990 Steroid receptor family: structure and function Endocrine Rev. 11 201-20
12. 3HTdR Radiat. Res. 67 332-43
13. Clarenc J P, Degols G, Leonetti J P, Milhaud P and Lebleu B 1993 Delivery of antisense oligonucleotides by poly (L-lysine) conjugation and liposome encapsulation Anti-Cancer Drug Design 8 81-94
14. Debruyne F M J and Dijkman G A 1995 Advances and trends in hormonal therapy for advanced prostate cancer Eur. Urology 28 177-88
15. Dehdashti F, Mortimer J E, Siegel B A, Griffeth L K, Bonasera T J, Fusselman M J, Detert D D, Cutler P D, Katzenellenbogen J A and Welch M J 1995 Positron tomographic assessment of estrogen receptors in breast cancer - comparison with FDG-PET and in vitro receptor assays J. Nucl. Med. 36 1766-74
16. de Sombre E R, Shafii B, Hanson R N, Kuivanen P C and Hughes A 1992 Estrogen receptor-directed radiotoxicity with Auger electrons - specificity and mean lethal dose Cancer Res. 52 5752-8
17. Ehrlich P 1906 Collected Studies on Immunity (New York: Wiley)
18. François J C, Saison-Behmoaras T, Barbier C, Chassignol M, Thuong N T and Hélène C 1989 Sequence-specific recognition and cleavage of duplex DNA via triple-helix formation by oligonucleotides covalently linked to phenanthroline-copper chelate Proc. Natl Acad. Sci. USA 86 9702-6
19. Frankkamenetskii M D and Mirkin S M 1995 Triplex DNA structures Ann. Rev. Biochem. 64 65-95
20. Garte S J 1993 The c-myc oncogene in tumor progression Crit. Rev. Oncogenesis 4 435-49
21. Gregoriadis G and Florence A T 1993 Liposomes in drug delivery Clinical, diagnostic and ophthalmic potential Drugs 45 15-28
22. Hanvey J C et al 1992 Antisense and antigene properties of peptide nucleic acids Science 258 1481-5
23. Heisterkamp K and Groffen J 1991 Molecular insights into the Philadelphia translocation Hematol. Pathol. 5 1-10
24. Hélène C 1991 The anti-gene strategy: control of gene expression by triplex-forming-oligonucleotides Anti-Cancer Drug Design 6 569-84
25. Hobisch A, Culig Z, Radmayr C, Bartsch G, Klocker H and Hittmair A 1995 Distant metastases from prostatic carcinoma express androgen receptor protein Cancer Res 55 3068-72
26. 3H: nuclear versus cytoplasmic radiation effects in murine L1210 leukaemia Int. J. Radiat. Biol. 28 225-41
27. 131iodine Radiat. Res. 47 94-109
28. Holt J A, Scharl A, Kullander S and Beckman M W 1992 Intracellular actions of steroid hormones and their therapeutic value, including the potential of radiohalosteroids against ovarian cancer Acta Obstet. Gyn. Scand. 155 (suppl.) 39-53
29. Howell R W 1992 Radiation spectra for Auger-electron emitting radionuclides: report No 2 of AAPM Nuclear Medicine Task Group No 6 Med. Phys. 19 1371-83
30. Howell R W, Kassis A I, Adelstein S J, Rao D V, Wright H A, Hamm R N, Turner J E and Sastry K S R 1994 Radiotoxicity of platinum-195m-labelled trans-platinum (II) in mammalian cells Radiat. Res. 140 55-62
31. Howell R W, Rao D V, Hou D Y, Narra V R and Sastry K S R 1991 The question of relative biological effectiveness and quality factor for auger emitters incorporated into proliferating mammalian cells Radiat. Res. 128 282-92
32. Hughes A, Gatley S J and de Sombre E R 1993 Comparison of the distribution of radioiodinated-E-17 alpha-iodovinyl-11 beta-methoxyestradiol and 2-iodo-1,1-bis (4-hydroxyphenyl)-phenylethylene estrogens in the immature rat J. Nucl. Med. 34 272-80
33. Humm J L 1986 Dosimetric aspects of radiolabelled antibodies for tumor therapy J. Nucl. Med. 27 1490-7
34. Humm J L and Charlton D E 1989 A new calculational method to assess the therapeutic potential of Auger electron emitters Int. J. Radiat. Oncol. Biol. Phys. 17 351-60
35. Humm J L, Howell R W and Rao D V 1994 Dosimetry of Auger-electron-emitting radionuclides: report No 3 of AAPM Nuclear Medicine Task Group No 6 Med. Phys. 21 1901-15
36. Kassis A I, Adelstein S J, Haydock C, Sastry K S R, McElvany K D and Welch M J 1982 Lethality of Auger electrons from the decay of bromine-77 in the DNA of mammalian cells Radiat. Res. 90 362-73
37. 125I-labelled DNA intercalator in mammalian cells Radiat. Res. 118 282-94
38. 125I in mammalian cells Radiat. Res. 111 305-18
39. 125I] iodo-2′-deoxyuridine in rat brain tumors: diagnostic and therapeutic implications in humans Cancer Res. 50 5199-203
40. Kearney T J, Hughes A and de Sombre E R 1995 Radiotoxicity of Auger electron-emitting estrogens for MCF-7 multicellular spheroids: a potential treatment for estrogen receptor positive tumors Proc. Annual Meeting Am. Assoc. Cancer Res. 36 A1603
41. Kern F G, Cheville A L and Liu Y 1990 Growth factor receptors and the progression of breast cancer Sem. Cancer Biol. 1 317-28
42. Klecker R W, Jenkins J F, Kinsella T J, Fine R L, Strong J M and Colline J M 1985 Clinical pharmacology of 5-iodo-2′-deoxyuridine and 5-iodouracil and endogenous pyrimidine modulation Clin. Pharmacol. Ther. 38 45-51
43. Libermann T A, Nusbaum H R, Razon N, Kris R, Lax I, Soreq H, Whittle N, Waterfield M D and Schlessinger J 1985 Amplification, enhanced expression and possible rearrangement of EGF receptor gene in primary human brain tumors of glial origin Nature 313 144-7
44. Lindström A and Carlsson J 1993 Penetration and binding of epidermal growth factor-dextran conjugates in spheroids of human glioma origin Cancer Biother. 8 145-58
45. 125I]iodo-2′-deoxyuridine in the treatment of colorectal cancer melastatic to the liver J. Nucl. Med. 37 (suppl) 25-9
46. Makela T P, Saksela K and Alitalo K 1992 Amplification and rearrangement of L-MYC in human small-cell lung cancer Mutation Res. 276 307-15
47. 125I] iodo-2′-deoxyuridine Radiat. Res. 118 532-44
48. Mariani G et al 1993 Tumor targetting in vivo and metabolic fate of 5-[iodine-125]iodo-2′-deoxyuridine following intratumoral injection in patients with colorectal cancer J. Nucl. Med. 34 1175-83
49. Marti U, Burwen S J, Wells A, Barker M, Huling S, Feren A M and Jones A L 1991 Localization of epidermal growth factor receptor in hepatocyte nuclei Hepatology 13 15-20
50. Martin R F and Haseltine W A 1981 Range of radiochemical damage to DNA with decay of iodine-125 Science 213 896-8
51. McDonnell T J, Marin M C, Hsu B, Brisbay S M, McConnell K, Tu S M, Campbell M L and Rodriguez-Villnueva J 1993 The bcl-2 oncogene: apoptosis and neoplasia Radiat. Res. 136 307-12
52. McShan W M, Rossen R D, Laughter A H, Trial J, Kessler D J, Zendegui J G, Hogan M E and Orson F M 1992 Inhibition of transcription of HIV-1 in infected human cells by oligodeoxynucleotides designed to form DNA triple helices J. Biol. Chem. 267 5712-21
53. Moser H E and Dervan P B 1987 Sequence-specific cleavage of double helical DNA by triple helix formation Science 238 645-50
54. Narra V R, Howell R W, Harapanhalli R S, Sastry K S R and Rao D V 1992 Radiotoxicity of some iodine-123, iodine-125 and iodine-131-labeled compounds in mouse testes: implications for radiopharmaceutical design J. Nucl. Med. 33 2196-201
55. Nielsen P E 1995 DNA analogues with nonphosphodiester backbones Ann. Rev. Biophys. Biomol. Struct. 24 167-83
56. O'Donoghue J A 1996 Strategies for selective targeting of Auger electron emitters to tumor cells J. Nucl. Med. 37 (suppl) 3-6
57. Okada T, Yamaguchi K and Yamashita Y 1994 Triplex-forming oligonucleotide binding represses transcription of the human c-erbB gene in glioma Growth Factors 11 259-70
58. Okada H and Toguchi H 1995 Biodegradable microspheres in drug delivery Crit. Rev. Ther. Drug Carrier Systems 12 1-99
59. Orson F M, Thomas D W, McShan W M, Kessler D J and Hogan M E 1991 Oligonucleotide inhibition of IL2Rα mRNA transcription by promoter region collinear triplex formation in lymphocytes Nucl. Acids Res. 19 3435-41
60. Ozawa S, Ueda M, Ando N, Abe O, Minoshima S and Shimzu N 1989 Selective killing of sqamous carcinoma cells by an immunotoxin that recognizes the EGF receptor Int. J. Cancer 43 152-9
61. 125I labelled oligonucleotides Nucl. Acids Res. 22 4979-82
62. Perrouault L, Asseline U, Rivalle C, Thuong N T, Bisagni E, Giovannangeli C, le Doan T and Hélène C 1990 Sequence-specific artificial photo-induced endonucleases based on triple helix-forming oligonucleotides Nature 344 358-60
63. Postel E H, Flint S J, Kessler D J and Hogan M E 1991 Evidence that a triplex-forming oligodeoxynucleotide binds to the c-myc promoter in HeLa cell, thereby reducing c-myc mRNA levels Proc. Natl Acad. Sci. USA 88 8227-31
64. Rakowicz-Szulczynska E M, Rodeck U, Herlyn M and Koprowski H 1986 Chromatin binding of epidermal growth factor, nerve growth factor and platelet derived growth factor in cells bearing the appropriate surface receptors Proc. Natl Acad. Sci. USA 83 3728-32
65. 125I compared with that of densely ionising alpha-particles Lancet ii 650-3
66. Ribeiro R C J, Kushner P J and Baxter J D 1995 The nuclear hormone receptor gene superfamily Ann. Rev. Med. 46 443-53
67. Rotmensch J, Schwartz J L, Atcher R W, Harper P V and de Sombre E 1991 Increased nuclear damage by high linear energy transfer radioisotopes applicable for radiodirected therapy against radiologie malignancies Gyn. Obstet. Invest. 33 180-4
68. Sastry K S R 1992 Biological effects of the Auger emitter iodine-125: a review. Report No 1 of AAPM Nuclear Medicine Task Group No 6 Med. Phys. 19 1361-70
69. Schneiderman M H and Hofer K G 1980 The target for radiation-induced division delay Radiat. Res. 84 462-76
70. Siegall C B, Fitzgerald D J and Pastan I 1990 Selective killing of tumour cells using EGF or TGFα-pseudomas exotoxin chimeric molecules Sem. Cancer Biol. 1 345-50
71. Snelling L, Miyamoto C T, Bender H, Brady L W, Steplewski Z, Class R, Emrich J and Rackover M A 1995 Epidermal growth factor receptor 425 monoclonal antibodies radiolabeled with iodine-125 in the adjuvant treatment of high-grade astrocytomas Hybridoma 14 111-14
72. Stull R A and Szoka F C 1995 Antigene, ribozyme and aptamer nucleic acid drugs: progress and prospects Pharmaceut. Res. 12 465-83
73. Takasugi M, Guendouz A, Chassignol M, Decout J L, Lhomme J, Thuong N T and Hélène C 1991 Sequence-specific photo-induced cross-linking of the two strands of double-helical DNA by a psoralen covalently linked to a triple helix-forming oligonucleotide Proc. Natl Acad. Sci. USA 88 5602-6
74. Thakur M K 1995 Androgen receptor and the mechanism of androgen action Curr. Sci. 68 806-12
75. Thomas T J, Faaland C A, Gallo MA and Thomas T 1995 Suppression of c-myc oncogene expression by a polyamine-complexed triplex forming oligonucleotide in MCF-7 breast cancer cells Nucl. Acids Res. 23 3594-9
76. Uhlmann E and Peyman A 1990 Antisense oligonucleotides: a new therapeutic principle Chem. Rev. 90 543-84
77. van Meervelt L, Vlieghe D, Dautant A, Gallois B, Precigoux G and Kennard O 1995 High-resolution structure of a DNA helix forming (C.G)*G base triplets Nature 374 742-4
78. Wang G, Levy D D, Seidman M M and Glazer P M 1995 Targetted mutagenesis in mammalian cells mediated by intracellular triple helix formation Mol. Cell. Biol. 15 1759-68
79. Willins J D and Sgouros G 1995 Modelling analysis of platinum-195m for targeting individual blood-borne cells in adjuvant radiotherapy J. Nucl. Med. 36 315-19
80. Wong Y F, Cheung T H, Lam S K, Zhuang Y L, Chan M T M and Chung T K H 1995 Prevalence and significance of HER-2/NEU amplification in epithelial ovarian cancer Gynecol. Obstet. Invest. 40 209-12
81. Yoshida T, Sakamoto H and Terada M 1993 Amplified genes in cancer in upper digestive tract Sem. Cancer Biol. 4 33-40